Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ORTC Ortec International -- Ignore unavailable to you. Want to Upgrade?

To: Jake who wrote (120)	4/1/1998 11:31:00 PM
From: fut_trade	Read Replies (1) \| Respond to of 272

It's in the most recent SEC filings. Also, last quarter's results. CUMULATIVE FROM MARCH 12, 1991 Year ended December 31, (INCEPTION) TO ------------------------------- DECEMBER 31, 1997 1996 1997 ------------ ------------ ------------ <S> <C> <C> <C> Revenue Interest income $ 291,602 $ 171,057 $ 529,817 ------------ ------------ ------------ Expenses Research and development 1,178,836 964,864 4,533,252 Rent 166,498 85,076 329,447 Consulting 474,908 261,633 1,232,304 Personnel 1,901,409 730,357 3,776,807 General and administrative 1,320,488 727,192 3,154,860 Interest and other expense 75,126 51,703 189,597 ------------ ------------ ------------ 5,117,265 2,820,825 13,216,267 ------------ ------------ ------------ Net loss $ (4,825,663) $ (2,649,768) $(12,686,450) ============ ============ ============ Net loss per share of common stock Basic and diluted $ (1.01) $ (.64) $ (4.44) ============ ============ ============ Weighted average common stock outstanding Basic and diluted 4,782,239 4,110,507 2,857,126 ============ ============ ============